Conversion from cyclosporine to FK 506 in liver allograft recipients with cyclosporine-related complications

Transplant Proc. 1990 Feb;22(1):6-12.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adolescent
  • Alanine Transaminase / blood
  • Anti-Bacterial Agents / adverse effects
  • Anti-Bacterial Agents / pharmacokinetics
  • Anti-Bacterial Agents / therapeutic use*
  • Aspartate Aminotransferases / blood
  • Child
  • Child, Preschool
  • Cyclosporins / adverse effects
  • Drug Evaluation
  • Female
  • Graft Rejection / drug effects
  • Humans
  • Immunosuppressive Agents* / adverse effects
  • Immunosuppressive Agents* / pharmacokinetics
  • Kidney / physiology
  • Liver Diseases / diagnosis
  • Liver Transplantation / immunology*
  • Male
  • Tacrolimus

Substances

  • Anti-Bacterial Agents
  • Cyclosporins
  • Immunosuppressive Agents
  • Aspartate Aminotransferases
  • Alanine Transaminase
  • Tacrolimus